Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease.

Remo BarnabeiGiulio Di MicheleAntonio CelliniGianfranco AmicosanteMariagrazia PerilliPierangelo BellioAlessandra PiccirilliGiuseppe Celenza

Published in: Clinical case reports (2021)

Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.

Keyphrases

sars cov
peripheral blood
coronavirus disease
chronic lymphocytic leukemia
respiratory syndrome coronavirus
case report
cerebral ischemia
replacement therapy